Develop Today To Improved Living Tomorrow

Taking on challenges of discovering therapeutics to address major unmet medical needs

AiViva is a clinical stage biotech company led by a team of seasoned industry experts with proven track record in drug development and commercialization. AiViva has discovered novel biology to address high unmet medical needs and to transform treatment paradigms through focal therapies. Core competencies include development of novel drugs using proprietary technologies, including JEL™, in Specialty Therapeutic Areas of Dermatology, Ophthalmology, Urology and Oncology.

Company Overview

About Us

Development Strategy

AiViva deploys an efficient, risk-mitigated development strategy that addresses diseases in specialty therapeutic areas where our innovative discoveries would provide a novel pharmacotherapy and/or reduce the treatment burden for both patients and physicians.

Scientific Approach